Quanterix Corporation to Present at 38th Annual J.P. Morgan Healthcare Conference
Company continues remarkable growth in 2019, fueled by new product launches, the acquisition of UmanDiagnostics, further validation in ground-breaking publications…
Pharmaceuticals, Biotechnology and Life Sciences
Company continues remarkable growth in 2019, fueled by new product launches, the acquisition of UmanDiagnostics, further validation in ground-breaking publications…
Indapta Developing First-in-class, Proprietary Cancer Therapy Based on a Specific, Potent Variety of Natural Killer Immune Cells for Use in…
DUBLIN–(BUSINESS WIRE)–The “Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future” report has been added…
NEW YORK–(BUSINESS WIRE)–Kramer Levin Naftalis & Frankel LLP today launched the Bio Law Blog, which provides insights into intellectual property…
– 20 Partnerships Added – – 62 Milestones Achieved – – More than 315 Total Therapeutic Programs at Year-End 2019…
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) announced today its Chief Executive Officer Geert Kersten will attend two upcoming healthcare…
NEWARK, Del.–(BUSINESS WIRE)–ANP Technologies Inc. (ANP) and Fulgent Pharma LLC through their partner Moffitt Cancer Center have successfully licensed the…
First Humira® Biosimilar to Launch in China GUANGZHOU, China–(BUSINESS WIRE)–#arthritis–Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, today announced that QLETLI®…
– TEOXANE SA RHA® portfolio: first and only range of FDA-approved dermal fillers for correction of dynamic wrinkles – –…